Guided by glycoproteins: Insights from antibody responses enable viral vaccine design

Viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the human immunodeficiency virus 1 (HIV-1) pose ongoing global health challenges, with significant implications for public health and economic stability. To effectively combat these viruses, it is crucial to investigate their properties, with the ultimate goal of developing antiviral drugs and preventive